Education
About Us
Working with TipRanks
Follow Us
Friedberg Ezra M Insider Profile
4 Followers
Friedberg Ezra M, Director at Humanigen, holds ― shares in Humanigen (Ticker: HGENQ), holds 134.57K shares in Pelthos Therapeutics (Ticker: PTHS). Most recently, Friedberg Ezra M ― shares of Humanigen on ― for an estimated value of ―.
Friedberg Ezra M Humanigen (HGENQ)Director
Humanigen (HGENQ)
Director
Not Ranked
Friedberg Ezra M has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Friedberg Ezra M's holdings
Insider Roles
Director
Roles that Friedberg Ezra M holds in companies
Most Profitable Insider Trade
The most profitable trade made by Friedberg Ezra M
Friedberg Ezra M's Trading History
Humanigen
―
―
―
―
Pelthos Therapeutics
Jul 03, 2025
Director
Informative Buy
800.00K
$4.25M
List of latest transactions for each holding click on a transaction to see Friedberg Ezra M's performance on stock
You May Also Like
Friedberg Ezra M insider profile FAQ
What is the percentage of profitable transactions made by Friedberg Ezra M?
The percentage of profitable transactions made by Friedberg Ezra M is ―.
What is the average return per transaction made by Friedberg Ezra M?
The average return per transaction made by Friedberg Ezra M is ―.
What stocks does Friedberg Ezra M hold?
Friedberg Ezra M holds: HGENQ, PTHS stocks.
What was Friedberg Ezra M’s latest transaction?
Friedberg Ezra M latest transaction was an Uninformative Buy of ―.
What was Friedberg Ezra M's most profitable transaction?
Friedberg Ezra M’s most profitable transaction was an Informative Buy of PTHS stock on July 3, 2025. The return on the trade was 74.30%.
What is Friedberg Ezra M's role in Humanigen?
Friedberg Ezra M's role in Humanigen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.